Associated Papers
Pachydermoperiostosis Associated With a Rare SLCO2A1 Mutation: A Case Report and Literature Review.
Mohammad M et al.
Cureus, 2025
Structure and transport mechanism of the human prostaglandin transporter SLCO2A1.
Xia Z et al.
Nature Communications, 2025
Structure and post-translational modification of the prostaglandin transporter.
Yu P et al.
Communications Biology, 2025
40681657 (PubMed )
Supplement: 42003_2025_8510_MOESM5_ESM.pdf
Primary hypertrophic osteoarthropathy: phenotypic variability and penetrance rate in heterozygotes for SLCO2A1 variants.
Arcanjo AM et al.
Jbmr Plus, 2025
Genotype and phenotype characterization of primary hypertrophic osteoarthropathy type 2 and chronic enteropathy associated with SLCO2A1: Report of two cases and literature review.
Kimball TN et al.
American Journal of Medical Genetics. Part A, 2024
Touraine-Solente-Gole syndrome: pathogenic variant in SLCO2A1 presented with polyarthralgia and digital clubbing.
Nicolau R et al.
Pediatric Rheumatology Online Journal, 2023
Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action.
Nakanishi T et al.
Pharmacology & Therapeutics, 2021
Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.
Guo T et al.
Molecular Medicine Reports, 2017
Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.
Lee S et al.
Journal of Korean Medical Science, 2016
Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.
Zhang Z et al.
The Journal of Clinical Endocrinology and Metabolism, 2013
Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.
Diggle CP et al.
Human Mutation, 2012
Select a paper to view details